| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| URGN | UroGen Pharma Ltd. | Belldegrun Arie | Director | Sep 14, 2022 | Option Exercise | $5.00 | 160,000 | 800,000 | 408,693 | Sep 16, 2022, 03:13 PM | |
| URGN | UroGen Pharma Ltd. | Belldegrun Arie | Director | Aug 31, 2022 | Option Exercise | $5.00 | 3,241 | 16,205 | 248,693 | Sep 02, 2022, 11:40 AM | |
| ALLO | Allogene Therapeutics, Inc. | Belldegrun Arie | Director | Jan 12, 2022 | Buy | $12.60 | 155,039 | 1,953,491 | 195,039 | Jan 14, 2022, 12:02 PM | |
| URGN | UroGen Pharma Ltd. | Belldegrun Arie | Director | Mar 26, 2021 | Option Exercise | $5.00 | 3,241 | 16,205 | 245,452 | Jun 09, 2021, 01:47 PM | |
| ALLO | Allogene Therapeutics, Inc. | Belldegrun Arie | Director | May 24, 2021 | Option Exercise | $18.22 | 379,066 | 6,906,582 | 583,034 | May 25, 2021, 08:00 AM | |
| URGN | UroGen Pharma Ltd. | Belldegrun Arie | Director | Mar 24, 2021 | Option Exercise | $5.00 | 3,241 | 16,205 | 245,452 | Apr 22, 2021, 05:19 PM | |
| KRON | Kronos Bio, Inc. | Belldegrun Arie | Director | Oct 14, 2020 | Option Exercise | $16.15 | 253,251 | 4,090,004 | 2,315,314 | Oct 16, 2020, 03:44 PM | |
| ALLO | Allogene Therapeutics, Inc. | Belldegrun Arie | Director | Jun 04, 2020 | Buy | $47.00 | 146,382 | 6,879,954 | 1,798,163 | Jun 04, 2020, 04:04 PM | |
| URGN | UroGen Pharma Ltd. | Belldegrun Arie | Director | Mar 27, 2019 | Option Exercise | $4.02 | 128,000 | 514,560 | 212,211 | Mar 28, 2019, 04:52 PM | |
| ALLO | Allogene Therapeutics, Inc. | Belldegrun Arie | Director | Oct 15, 2018 | Buy | $18.00 | 194,445 | 3,500,010 | 1,691,781 | Feb 13, 2019, 05:10 PM | |
| ALLO | Allogene Therapeutics, Inc. | Belldegrun Arie | Director | Oct 15, 2018 | Buy | $18.00 | 35,000 | 630,000 | 35,000 | Oct 17, 2018, 05:29 PM | |
| KITE | Kite Pharma, Inc. | Belldegrun Arie | Chairman, President and CEO | Oct 03, 2017 | Option Exercise | $180.00 | 3,197,269 | 575,508,420 | 0 | Oct 05, 2017, 08:10 PM | |
| KITE | Kite Pharma, Inc. | Belldegrun Arie | Chairman, President and CEO | Sep 25, 2017 | Sale | $179.66 | 26,347 | 4,733,607 | 109,160 | Sep 27, 2017, 09:38 PM | |
| KITE | Kite Pharma, Inc. | Belldegrun Arie | Chairman, President and CEO | May 09, 2017 | Buy | $68.57 | 17,000 | 1,165,690 | 85,507 | May 09, 2017, 03:37 PM | |
| KITE | Kite Pharma, Inc. | Belldegrun Arie | Chairman, President and CEO | Dec 20, 2016 | Sale | $50.86 | 3,493 | 177,654 | 24,707 | Dec 22, 2016, 04:47 PM | |
| ARNI | Arno Therapeutics, Inc | Belldegrun Arie | Director | Jan 12, 2016 | Buy | $0.35 | 1,448,062 | 506,822 | 1,548,543 | Jan 14, 2016, 05:19 PM | |
| ARNI | Arno Therapeutics, Inc | Belldegrun Arie | Director | Jan 12, 2016 | Buy | $0.35 | 714,285 | 250,000 | 858,094 | Jan 14, 2016, 05:19 PM | |
| ARNI | Arno Therapeutics, Inc | Belldegrun Arie | Director | Oct 29, 2013 | Option Exercise | $2.40 | 95,537 | 229,289 | 100,481 | Nov 05, 2013, 10:08 AM | |
| ARNI | Arno Therapeutics, Inc | Belldegrun Arie | Director | Oct 29, 2013 | Option Exercise | $2.40 | 71,652 | 171,965 | 91,312 | Nov 05, 2013, 10:08 AM | |
| ARNI | Arno Therapeutics, Inc | Belldegrun Arie | Director | Oct 29, 2013 | Option Exercise | $2.40 | 143,305 | 343,932 | 150,721 | Nov 05, 2013, 10:08 AM | |
| ARNI | Arno Therapeutics, Inc | Belldegrun Arie | Director | Oct 29, 2013 | Option Exercise | $2.40 | 167,189 | 401,254 | 191,794 | Nov 05, 2013, 10:08 AM | |
| ARNI | Arno Therapeutics, Inc | Belldegrun Arie | Director | May 28, 2013 | Option Exercise | $0.30 | 9,667 | 2,900 | 157,286 | Jun 03, 2013, 04:46 PM | |
| ARNI | Arno Therapeutics, Inc | Belldegrun Arie | Director | May 28, 2013 | Option Exercise | $0.30 | 12,889 | 3,867 | 39,555 | Jun 03, 2013, 04:46 PM | |
| ARNI | Arno Therapeutics, Inc | Belldegrun Arie | Director | May 28, 2013 | Option Exercise | $0.30 | 22,556 | 6,767 | 196,841 | Jun 03, 2013, 04:46 PM | |
| ARNI | Arno Therapeutics, Inc | Belldegrun Arie | Director | May 28, 2013 | Option Exercise | $0.30 | 19,333 | 5,800 | 59,333 | Jun 03, 2013, 04:46 PM | |
| ARNI | Arno Therapeutics, Inc | Belldegrun Arie | Director | Apr 29, 2013 | Option Exercise | $0.30 | 13,333 | 4,000 | 26,666 | May 07, 2013, 12:20 PM | |
| ARNI | Arno Therapeutics, Inc | Belldegrun Arie | Director | Apr 29, 2013 | Option Exercise | $0.30 | 23,333 | 7,000 | 174,285 | May 07, 2013, 12:20 PM | |
| ARNI | Arno Therapeutics, Inc | Belldegrun Arie | Director | Apr 29, 2013 | Option Exercise | $0.30 | 20,000 | 6,000 | 40,000 | May 07, 2013, 12:20 PM | |
| ARNI | Arno Therapeutics, Inc | Belldegrun Arie | Director | Apr 29, 2013 | Option Exercise | $0.30 | 10,000 | 3,000 | 147,619 | May 07, 2013, 12:20 PM | |
| ARNI | Arno Therapeutics, Inc | Belldegrun Arie | Director | Mar 27, 2013 | Option Exercise | $0.30 | 13,333 | 4,000 | 13,333 | Apr 15, 2013, 09:32 AM | |
| ARNI | Arno Therapeutics, Inc | Belldegrun Arie | Director | Mar 27, 2013 | Option Exercise | $0.30 | 23,333 | 7,000 | 150,952 | Apr 15, 2013, 09:32 AM | |
| ARNI | Arno Therapeutics, Inc | Belldegrun Arie | Director | Mar 27, 2013 | Option Exercise | $0.30 | 20,000 | 6,000 | 20,000 | Apr 15, 2013, 09:32 AM | |
| ARNI | Arno Therapeutics, Inc | Belldegrun Arie | Director | Mar 27, 2013 | Option Exercise | $0.30 | 10,000 | 3,000 | 137,619 | Apr 15, 2013, 09:32 AM |
Menu